Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Arcellx Inc COMMON STOCK | 3,146,630 | 2,346,630 | -800,000 | $174.64M | $163.21M | 44.83% | -$11.43M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 0 | 1,048,951 | +1,048,951 | $0 | $71.50M | 19.64% | +$71.50M |
| ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | 4,012,903 | 0 | $21.99M | $41.01M | 11.26% | +$19.02M |
| Nkarta, Inc.(NKTX) | 1,333,333 | 3,333,333 | +2,000,000 | $8.80M | $36.03M | 9.90% | +$27.23M |
| Design Therapeutics, Inc.(DSGN) | 6,526,476 | 6,526,476 | 0 | $17.30M | $26.30M | 7.22% | +$9.01M |
| Mineralys Therapeutics, Inc.(MLYS) | 1,794,600 | 2,016,822 | +222,222 | $15.43M | $26.04M | 7.15% | +$10.60M |